Table 1. Definitive pathology findings from brain biopsy and associated interpretation of findings.
Marker | Results | Interpretation |
CD 5 | Negative | Decreased likelihood of T-cell lymphoma and chronic B-cell leukemia |
CD 10 | Negative | Decreased likelihood of acute leukemia and follicular lymphoma |
CD 19 | Positive | Highly suggestive of B-cell malignancy and available target for CAR-T and monoclonal antibody medications |
CD 20 | Positive | Suggests active B-cells; expressed in B-cell lymphomas |
CD 23 | Negative | Decreased likelihood B-cells involved in capturing IgE-antigen complexes |
CD 38 | Equivocal | Decreased likelihood that HIV seroconversion is occurring |
CD 45 | Positive | Increased likelihood of B-cell leukemia or lymphoma |
FMC7 | Positive | Strong likelihood of B-cell NHL or chronic lymphocytic leukemia [7] |
Additional findings | Aberrant population (<1%) of lambda light chain restricted | Highly suggestive of malignant B-cell proliferation and movement away from normal kappa/lambda ratio of 1:1 to 1:2 [8] |